UnitedHealth Group (NYSE:UNH) Stock Price Down 0.8%

Shares of UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) traded down 0.8% during mid-day trading on Monday . The company traded as low as $490.57 and last traded at $491.20. 422,594 shares were traded during trading, a decline of 91% from the average session volume of 4,457,367 shares. The stock had previously closed at $495.35.

Analyst Ratings Changes

Several research firms have commented on UNH. TD Cowen dropped their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating for the company in a research note on Wednesday, April 10th. Piper Sandler increased their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a "buy" rating in a research note on Friday, April 19th. Stephens restated an "overweight" rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Oppenheimer reiterated an "outperform" rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $570.05.

UnitedHealth Group Price Performance

The firm has a market cap of $449.92 billion, a price-to-earnings ratio of 30.02, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The stock's 50 day simple moving average is $485.84 and its 200-day simple moving average is $514.07.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analysts' expectations of $99.23 billion. During the same quarter in the previous year, the firm posted $6.26 EPS. The firm's revenue was up 8.6% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group's dividend payout ratio (DPR) is presently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 858 shares of the business's stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Bensler LLC boosted its holdings in shares of UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate's stock worth $3,677,000 after purchasing an additional 19 shares during the last quarter. Texas Capital Bancshares Inc TX raised its holdings in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate's stock worth $855,000 after acquiring an additional 19 shares during the period. Tealwood Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate's stock valued at $2,626,000 after purchasing an additional 19 shares during the period. Atlas Private Wealth Advisors raised its stake in UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate's stock worth $923,000 after purchasing an additional 19 shares during the period. Finally, Prentice Wealth Management LLC grew its stake in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate's stock valued at $1,235,000 after buying an additional 19 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.